CoChat

Therapeutic Role of l-Theanine in Mitigating Cognitive Dysfunction and Neuropathology in Scopolamine-Treated Mice

Elbaz, Eman M., Ibrahim, Sherehan M., Rashad, Eman, Yasin, Noha A. E., Ghaiad, Heba R., Mehana, Noha A. · 2025 · ACS Chemical Neuroscience

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Abstract

Memory decline is a prominent hallmark of Alzheimer's disease (AD). Scopolamine-induced amnesia is a pharmacological paradigm in AD research to model these cognitive insults. AD represents the most prevalent type of dementia among the elderly, depicted by impaired cognition and memory. AD pathogenesis is an interplay among cholinergic signaling disruption, neuroinflammation, and oxidative stress. Recently, autophagy modulation has been proven to display a beneficial effect against several diseases. l-Theanine (LTA), found in green tea, possesses neuroprotective, anti-inflammatory, antioxidant, and antiaging properties. Hence, this study investigated LTA's potential to alleviate AD symptoms, elaborating the role of autophagy. 45 mice were classified into five groups: the control, where animals received phosphate-buffered saline, while the other groups received scopolamine (Scop; 1 mg/kg; i.p.), inducing amnesia; then they were categorized as follows: group II represented the model one, group III was treated with donepezil (DON; 5 mg/kg; p.o.), while group IV was treated with LTA (20 mg/kg; p.o.), and group V received chloroquine (CQ; 10 mg/kg; p.o.), an autophagy blocker, followed by LTA. LTA stimulated AMP-activated protein kinase (AMPK), microtubule-associated protein-1 light chain-3II (LC3II), and beclin 1 but lowered phosphorylated levels of protein kinase B (p-AKT) and mammalian target of rapamycin (p-mTOR). Furthermore, LTA elevated the brain-derived neurotrophic factor (BDNF) and downregulated caspase-3 expression. Noteworthily, LTA increased glutathione and reduced malondialdehyde and tumor necrosis factor-alpha levels. In conclusion, LTA ameliorated histopathological changes, reduced amyloid-β, and enhanced learning and memory performance in novel object recognition, Y-maze, and Morris water maze. LTA boosted autophagy, promoted neuronal survival, and attenuated oxidative stress. LTA almost displayed similar effects to the DON group, while CQ abolished LTA-enhanced memory via blocking autophagy. Consequently, LTA-mediated autophagy represents a promising approach to alleviating Scop-induced amnesia in mice.

Overview

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.5c00351

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. Zhu B., 2014, Int. J. Clin. Exp. Med., 7, 3327

Cited by

See all 21

Metadata

Authors
Elbaz, E. M., Ibrahim, S. M., Rashad, E., Yasin, N. A. E., Ghaiad, H. R., & Mehana, N. A.
Affiliations
Cairo University (EG)
Corresponding author
Ghaiad, Heba R.
Venue
ACS Chemical Neuroscience
Published
2025-06-12
Volume
16
Issue
13
Pages
2528-2545
ISSN
1948-7193 (ISSN-L)
OpenAlex
W4411224704
Cited by
21
References
126
Citations by year
2026: 16 · 2025: 5
FWCI
13.38
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
theanine, Alzheimer's disease, scopolamine-induced amnesia, autophagy, cognitive impairment, memory impairment, AMPK signaling, LC3-II, Beclin-1, Akt/mTOR signaling, brain-derived neurotrophic factor, caspase-3, oxidative stress, neuroinflammation, amyloid-beta, neuroprotection, chloroquine
MeSH terms
Alzheimer Disease, Amnesia, Animals, Autophagy, Disease Models, Animal, Glutamates, Hippocampus, Male, Scopolamine, Oxidative Stress, Neuroprotective Agents, Maze Learning, Mice, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.